Independent coverage of UK markets, FCA policy and institutional trading
Google has spent years pitching customers on the advantage of buying its chips, models and cloud services in one place, offering a full stack that rivals Amazon and Microsoft have tried to replicate.
Join over half a million readers using Kiplinger's insights to make smart financial decisions. Profit and prosper with our expert guidance on investing, taxes and retirement, and more. Delivered daily…
The artificial intelligence (AI) frenzy remains intact as the AI infrastructure space remains rock solid, supported by an extremely bullish demand scenario. Research firm McKinsey & Co. has estimated …
Budget 2026: six charts that reveal the economic realities facing the chancellor
Generac Holdings Inc. GNRC expects to generate approximately $350 million in free cash flow in 2026, even as it increases capital spending to expand production capacity and capitalize on growing deman…
Jim Cramer's top 10 things to watch in the stock market Wednesday SK Hynix blew away the numbers, and GE Vernova crushed it too. Read at source
Shares of Stellantis were up Wednesday as the European car giant's third-quarter results showed it was making progress with its 60 billion euro turnaround plan.
At least 64 people have been killed in a collision between two trains in the Spanish province of Toledo.
August 5, 2026, 3:53 AM EDT.IPOs such as SpaceX and ChangXin Memory Technologies have generated worldwide interest, particularly across the tech and AI sectors. Still, with founders trying to maximize…
Elevator manufacturer Otis (NYSE:OTIS) will be reporting earnings this Wednesday before market hours. Hereâs what to expect.
A group of investors led by Nelson Peltz's Trian Fund Management has offered $1.4 billion to buy Wendy's, according to a regulatory filing Wednesday.
The "Magnificent Seven" doesn't trade as a monolith anymore, challenging investors to be more discerning when picking through the market's biggest stocks rather than viewing them as a single trade.
What are the best stocks to buy right now? There are thousands of publicly traded companies you can invest in. That doesn't even include the many exchange-traded funds (ETFs) and mutual funds you can …
The benchmark KOSPI rose 337.64 points, or 5.99%, to 5,975.98 as of 0140 GMT. If the gains hold, the index would record its biggest single-day percentage rise since July 31, as per the report.
Investors are pricing in a higher likelihood that the Federal Reserve will hike rates after core CPI inflation rose in August more than economists had estimated. However, a rate hike may not keep the …
British pharma company reports declining profits amid weaker vaccine sales and looming patent loss for blockbuster HIV drug
Oil prices climbed Wednesday as investors weighed the prospect of a prolonged and widening Middle East conflict after Tehran-backed Houthis attacked Saudi Arabia's largest refinery.
Samsung Electro-Mechanics (009150.KS) shares rocketed to their daily price limit early in the session. The surge was fueled by a concentrated wave of buying after the company reported second-quarter e…
UBS reported a pre-tax profit of almost $3.6 billion in the third quarter, up 27% year on year, largely in line with consensus forecasts.
The loan-satisfaction agreements exchange debt for convertible preferred shares and warrants, with conversion and exercise subject to shareholder approval.
CBIZ stockholders preliminarily approved the proposed merger with Viking ParentCo and Viking MergerCo at a special meeting.
President Donald Trump joked that the $5,000 payments he's promised U.S. adults would buy little more than "a hamburger and maybe a small dessert" at his Mar-a-Lago club in Florida, a week before midt…
Jio Platforms' shares rose 21.4% on their trading debut Wednesday after a record initial public offering that was lapped up by retail as well as institutional investors.
WAYNE, Pa., Oct. 27, 2026 (GLOBE NEWSWIRE) -- Aclaris Therapeutics, Inc. (NASDAQ: ACRS), a clinical-stage biopharmaceutical company focused on developing novel product candidates for immuno-inflammato…